Dr. Helen MacKay, MD
Claim this profileSunnybrook Health Sciences Centre
Studies Ovarian Cancer
Studies Cancer
7 reported clinical trials
19 drugs studied
Area of expertise
1Ovarian Cancer
Stage IV
MSI
advanced
2Cancer
Affiliated Hospitals
Clinical Trials Helen MacKay, MD is currently running
Genetic-Based Adjuvant Therapy
for Endometrial Cancer
This protocol tests de-escalated adjuvant treatment in patients with POLE-mutated or p53wt/NSMP (p53 wildtype/no specific molecular profile) early-stage endometrial cancer (EC). Patients may be enrolled in one of two sub-studies * EN10.A/RAINBO BLUE: POLE-mutated EC * EN10.B/TAPER: p53 wildtype / NSMP EC
Recruiting1 award Phase 2
Olaparib + Navitoclax
for Breast Cancer
This trial tests a combination of two drugs, olaparib and navitoclax, in women with specific genetic mutations in aggressive breast and ovarian cancers. Olaparib weakens the cancer cells, and navitoclax helps kill them. The goal is to find a safe and effective dose for future studies. Olaparib has been approved for use in patients with advanced ovarian cancer.
Recruiting1 award Phase 114 criteria
More about Helen MacKay, MD
Clinical Trial Related5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Helen MacKay, MD has experience with
- Olaparib
- Durvalumab
- Cediranib Maleate
- Capivasertib
- Personalize My Treatment (PMT) Registry
- DPX-Survivac
Breakdown of trials Helen MacKay, MD has run
Ovarian Cancer
Endometrial Cancer
Serous Cystadenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Helen MacKay, MD specialize in?
Helen MacKay, MD focuses on Ovarian Cancer and Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are MSI.
Is Helen MacKay, MD currently recruiting for clinical trials?
Yes, Helen MacKay, MD is currently recruiting for 4 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Helen MacKay, MD has studied deeply?
Yes, Helen MacKay, MD has studied treatments such as Olaparib, Durvalumab, Cediranib Maleate.
What is the best way to schedule an appointment with Helen MacKay, MD?
Apply for one of the trials that Helen MacKay, MD is conducting.
What is the office address of Helen MacKay, MD?
The office of Helen MacKay, MD is located at: Sunnybrook Health Sciences Centre, Toronto, Ontario M4N 3M5 Canada. This is the address for their practice at the Sunnybrook Health Sciences Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.